Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
29 Cards in this Set
- Front
- Back
where in the stem cell differentiation does NHL occur
|
lymphoid stem cell
|
|
what is the function of B cells and T cells
|
B cells = humoral immunity
T cells = cell mediated immunity |
|
what factors increase risk of NHL
|
immunosuppression (transplant, auto immune disorders)
infectious agents environmental genetic abnormalities |
|
what genetic abnormalities increase risk of NHL
|
t (8;14) - burkets
t (14; 18) - follicular t (11;14) |
|
what infectious agents increase risk of NHL
|
epstein barr virus
HTLV-1 Herpes H. pylori |
|
what classification is Diffuse Large Cell lymphoma
|
aggressive
|
|
what classification of NHL is not curable
|
indolent b/c it grows slows and won't respond to chemo
|
|
how does NHL present
|
asymptomatic
peripheral lympadenopathy fatigue, malaise, pruritis B symptoms extranodal disease |
|
what are the B symptoms
|
fever (>100,4 F or 38 C)
night sweats weight loss ( > 10% tbw over 6 months must be unintentional/unexplained) |
|
what are the stages of the Ann Arbor staging system
|
stage 1 = disease in single LN or small LN group
stage 2 = disease in two or more LN on SAME SIDE of diaphragm and/or spleen stage 3 = disease on BOTH SIDES of diaphragm and/or spleen stage 4 = disease in extranodal sites |
|
what do the various subscripts mean
A B E X |
A - no B symptoms
B - B symptoms E - extranodal site X - bulky tumor > 10 cm |
|
what are the international prognostic index factors
|
age > 60
performance status >= 2 lactate dehydrogenase (LDH) > NORMAL extranodal sites >= 2 stage 3 or 4 ***one point for each low 0-1 low/intermediate 2 high/intermediate 3 high 4-5 |
|
what are the treatment modalities for NHL
|
chemotherapy
biological therapy radiation therapy stem cell transplant |
|
what is used in biological therapy and how does it work
|
Rituximab is used and it works by targeting CD20
|
|
what are the mechanisms of action of rituximab
|
antibody cell mediated cytotoxicity
complement dependent killing initiation of apoptosis |
|
read up on radiation therapy
|
read up on radiation therapy
|
|
what is the purpose of Stem cell transplant in NHL pts
|
the pt must first be chemosensitive
they are then given a high dose of chemotherapy used to wipe out the lymphoma then given autologous stemm cells to help bone marrow recover from chemo given |
|
how is Diffuse large B cell lymphoma treated
|
R-CHOP
rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone |
|
what are the 1st line therapies for DLBCL
|
1) R-CHOP q 21 days
2)R-CHOP q 14 days 2)R-EPOCH 2)Autologous SCT |
|
what is the first line therapy for a pt that presents with
Stage 1/2, Non-Bulky <10 cm, no adverse risk factors |
RCHOP 3 cycles + RT
|
|
what is the first line therapy for a pt that presents with
Stage 1/2, Non-Bulky <10 cm, w/ adverse risk factors |
RCHOP 6-8 cycles +/- RT
|
|
what is the first line therapy for a pt that presents with
Stage 1/2, Bulky >10 cm |
RCHOP 6-8 cycles + RT
|
|
what is the first line therapy for a pt that presents with
Stage 3/4 |
RCHOP 6-8 cycles
|
|
what are the SE of RCHOP
|
rituximab - infusion reactions
cyclophosphamide - hemorrhagic cystitis doxorubicin - cardiotoxicity vincristine - neurotoxicity prednisone - ulcers, HTN, hyperglycemia myelosuppression, n/v, alopecia in general |
|
what is used for CNS prophylaxis in DLBCL
|
4-8 doses of methotrexate and/or cytaribine usually given once per cycle
|
|
what patients is CNS prophylaxis for DLBCL recommended
|
testicular, paranasal sinus, epidural, bone marrow involvement
AIDS related lymphoma >= 2 extranodal sites |
|
what is 2nd line (salvage) therapy for DLBCL
|
chemotherapy + autologous SCT
|
|
what is the treatment of choice for relapsed/refractory chemosensitive DLBCL pts
|
chemotherapy + autologous SCT
|
|
what is the treatment of choice for newly diagnosed pts
|
R-CHOP
|